Cargando…
Photoimmunotherapy of Ovarian Cancer: A Unique Niche in the Management of Advanced Disease
Ovarian cancer (OvCa) is the leading cause of gynecological cancer-related deaths in the United States, with five-year survival rates of 15–20% for stage III cancers and 5% for stage IV cancers. The standard of care for advanced OvCa involves surgical debulking of disseminated disease in the periton...
Autores principales: | Nath, Shubhankar, Saad, Mohammad Ahsan, Pigula, Michael, Swain, Joseph W.R., Hasan, Tayyaba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966499/ https://www.ncbi.nlm.nih.gov/pubmed/31783651 http://dx.doi.org/10.3390/cancers11121887 |
Ejemplares similares
-
Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress
por: Nath, Shubhankar, et al.
Publicado: (2020) -
A Dual Function Antibody Conjugate Enabled Photoimmunotherapy Complements Fluorescence and Photoacoustic Imaging of Head and Neck Cancer Spheroids
por: Saad, Mohammad A., et al.
Publicado: (2023) -
Photoimmunotherapy retains its anti-tumor efficacy with increasing stromal content in heterotypic pancreatic cancer spheroids
por: Saad, Mohammad A., et al.
Publicado: (2022) -
Fluorescence-guided photoimmunotherapy using targeted nanotechnology and ML7710 to manage peritoneal carcinomatosis
por: Liang, Barry J., et al.
Publicado: (2023) -
Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model.
por: Goff, B. A., et al.
Publicado: (1994)